XprESS ET Registry

NCT ID: NCT04136977

Last Updated: 2020-09-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

169 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-06-05

Study Completion Date

2020-08-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A prospective, multicenter, registry of patients undergoing balloon dilation of the Eustachian tubes (ET).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective, multicenter, single-arm, postmarket registry enrolling up to 300 participants who are planning to undergo balloon dilation of the Eustachian tubes for treatment of chronic/persistent Eustachian tube dysfunction (ETD). Procedural information will be collect as well as efficacy and safety data through 6 months post procedure.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Eustachian Tube Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Eustachian tube dilation

Unilateral or bilateral balloon dilation of the Eustachian tube using the FDA-cleared XprESS ENT Dilation System

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

XprESS ET balloon dilation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Be at least 18 years old
* Have been diagnosed with persistent/chronic Eustachian tube dysfunction (duration 3 months or more)
* Be a candidate for unilateral or bilateral Eustachian tube balloon dilation using the XprESS device
* Be able to read and understand English
* Be willing and able to provide informed consent
* Be willing to comply with the protocol requirements

Exclusion Criteria

* Have a history of patulous Eustachian tube
* Require additional ear surgery (eg, myringotomy, tympanostomy) at the time of study procedure
* Have evidence of internal carotid artery dehiscence
* Be currently participating in any other drug or device clinical studies, excluding postapproval or marketing registry studies
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

North American Science Associates Ltd.

NETWORK

Sponsor Role collaborator

Entellus Medical, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Edward D McCoul, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Ochsner Health System, New Orleans, LA

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Breathe Clear Institute

Torrance, California, United States

Site Status

Colorado ENT and Allergy

Colorado Springs, Colorado, United States

Site Status

Augusta ENT and Allergy

Evans, Georgia, United States

Site Status

St. Vincent Anderson Hospital

Anderson, Indiana, United States

Site Status

Ochsner Clinic Foundation

New Orleans, Louisiana, United States

Site Status

Ear Nose and Throat Consultants

Southfield, Michigan, United States

Site Status

St Cloud ENT

Saint Cloud, Minnesota, United States

Site Status

ENT Consultants of Nevada

Las Vegas, Nevada, United States

Site Status

Lakeside ENT

Canandaigua, New York, United States

Site Status

National Allergy and ENT

Charleston, South Carolina, United States

Site Status

Medical University of South Carolina

Charleston, South Carolina, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Swords C, Smith ME, Patel A, Norman G, Llewellyn A, Tysome JR. Balloon dilatation of the Eustachian tube for obstructive Eustachian tube dysfunction in adults. Cochrane Database Syst Rev. 2025 Feb 26;2(2):CD013429. doi: 10.1002/14651858.CD013429.pub2.

Reference Type DERIVED
PMID: 40008607 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

4079-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Evaluation of the Tympanostomy Tube Delivery System
NCT01202578 COMPLETED PHASE2/PHASE3
CI532 - Early Experience Study
NCT02755935 COMPLETED NA